Upexi(UPXI)
搜索文档
Upexi(UPXI) - 2023 Q4 - Annual Report
2023-10-03 18:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2023 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ____________ Commission file number 333-255266 UPEXI, INC. (Exact name of registrant as specified in its charter) Nevada 83-3378978 (State or other jurisdiction ...
Upexi (UPXI) Presents At Inaugural Global Conference - Slideshow
2023-05-18 22:46
业绩总结 - Upexi公司预计2022年财年营收和EBITDA将分别达到44.58百万美元和3.4百万美元[26] - 公司预计2023年全年营收将达到1亿美元,股价为4.12美元[29] 用户数据 - Vita-Medica品牌自2021年底以来有88%的有机增长[10] - Tytan Tiles品牌在2022年实现了100%的有机增长[12] - Cygnet Online品牌在2022年贡献了约2200万美元的收入[15] 新产品和新技术研发 - Upexi公司拥有专有技术和数据平台,能够增加跨品牌销售[13] 市场扩张和并购 - Upexi公司寻找收购目标时注重高利润业务、数据丰富的客户列表和协同效应[19] - 公司计划通过收购成功品牌实现未来增长和成本效益[23] - 公司管理团队拥有丰富的并购经验,内部持股比例高达54%[24] 其他新策略和有价值的信息 - Upexi公司是Amazon和批发清算品牌和业务的大规模清算者[22] - 公司为目标公司提供技术整合、广告营销和产品开发团队[20]
Upexi(UPXI) - 2023 Q3 - Quarterly Report
2023-05-16 05:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to _______ Commission File Number 333-255266 UPEXI, INC. (Exact name of registrant as specified in its charter) Nevada 83-3378978 (State or other jurisdiction of (I ...
Upexi(UPXI) - 2023 Q4 - Earnings Call Presentation
2023-02-17 15:44
Innovation in Aggregation We Build, Buy & Scale Amazon And eCommerce Brands February 2023 Investor Presentation NASDAQ: UPXI Forward Looking Information This presentation contains "forward-looking statements", including statements regarding Grove, Inc. and its subsidiaries, within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. All of the statements in this presentation, including financial projections, whether written or oral, that refer to expected or a ...
Upexi(UPXI) - 2023 Q2 - Earnings Call Transcript
2023-02-16 06:17
Upexi, Inc. (NASDAQ:UPXI) Q2 2023 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Valter Pinto - MD of KCSA Strategic Communications Allan Marshall - CEO Andrew Norstrud - CFO Conference Call Participants Michael Albanese - EF Hutton Aaron Grey - Alliance Global Partners Operator Greetings and welcome to the Upexi, Inc. 2023 Fiscal Second Quarter Earnings Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will fol ...
Upexi(UPXI) - 2023 Q2 - Quarterly Report
2023-02-15 19:37
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to _______ Commission File Number 333-255266 UPEXI, INC. (Exact name of registrant as specified in its charter) Nevada 83-3378978 (State or other jurisdiction of ...
Upexi(UPXI) - 2023 Q1 - Earnings Call Transcript
2022-11-17 04:46
Upexi, Inc. (NASDAQ:UPXI) Q1 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Valter Pinto - Managing Director of KCSA Strategic Communications Allan Marshall - Chief Executive Officer Andrew Norstrud - Chief Financial Officer Conference Call Participants Benjamin Piggott - EF Hutton Operator Good afternoon. I will be your conference operator today. At this time, I would like to welcome everyone to the Upexi's 2023 Fiscal First Quarter Financial Results Conference Call. Please ...